Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-04

FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PREMPRO, a combination of conjugated estrogens and medroxyprogesterone acetate, from Wyeth Pharmaceuticals (Pfiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREMPRO (Conjugated estrogens and medroxyprogesterone acetate)

Snippet

SUPPL AP for PREMPRO (CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE)